RSP’s non-invasive GlucoBeam technology continues to prove its performance even in comparison with invasive blood glucose measurement technologies. Latest, Dr. med. Guido Freckmann presented a poster at the 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), February 19-22, 2020 in Madrid, showing a favourable outcome for GlucoBeam in comparison with established Flash Glucose (iscCGM).
The study was set up to assess the performance of GlucoBeam in a comparison with standard capillary blood glucose monitoring (BGM) and with intermittent scanning continuous glucose monitoring (iscCGM). The study demonstrated that average glucose concentration data from GlucoBeam were consistent with data from blood and intermittent scanned continuous glucometers.